Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy

被引:123
|
作者
Wu, Wei [1 ]
Zhou, Qiuping [1 ]
Masubuchi, Takeya [2 ]
Shi, Xiaoshan [1 ,3 ,12 ,13 ]
Li, Hua [1 ]
Xu, Xinyi [1 ]
Huang, Min [1 ]
Meng, Li [1 ]
He, Xing [1 ]
Zhu, Hengyu [1 ]
Gao, Shuaixin [3 ]
Zhang, Nan [3 ]
Jing, Ruirui [4 ,5 ,6 ,7 ]
Sun, Jie [4 ,5 ,6 ,7 ]
Wang, Haopeng [8 ]
Hui, Enfu [2 ]
Wong, Catherine Chiulan [1 ,3 ,9 ,10 ]
Xu, Chenqi [1 ,11 ]
机构
[1] Univ Chinese Acad Sci, Chinese Acad Sci, Ctr Excellence Mol Cell Sci, State Key Lab Mol Biol,Shanghai Inst Biochem & Ce, Shanghai 200031, Peoples R China
[2] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA
[3] Peking Univ, Hlth Sci Ctr, Hosp 1, Ctr Precis Med Multiom Res, Beijing 100191, Peoples R China
[4] Zhejiang Univ, Bone Marrow Transplantat Ctr, Affiliated Hosp 1, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China
[5] Zhejiang Univ, Sch Med, Dept Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China
[6] Zhejiang Univ, Inst Hematol, Hangzhou 310058, Zhejiang, Peoples R China
[7] Lab Stem Cell & Immunotherapy Engn, Hangzhou 310058, Zhejiang, Peoples R China
[8] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China
[9] Peking Univ, Sch Basic Med Sci, Hlth Sci Ctr, Beijing 100191, Peoples R China
[10] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China
[11] Univ Chinese Acad Sci, Sch Life Sci, Hangzhou Inst Adv Study, Hangzhou 310024, Zhejiang, Peoples R China
[12] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA
[13] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
PROLINE-RICH SEQUENCE; RECEPTOR ZETA; TYROSINE PHOSPHORYLATION; ABSOLUTE QUANTIFICATION; MEMBRANE ASSOCIATION; ACTIVATION MOTIFS; SUBUNIT CONTAINS; BINDING MOTIF; KINASE CSK; TCR-ZETA;
D O I
10.1016/j.cell.2020.07.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A T cell receptor (TCR) mediates antigen-induced signaling through its associated CD3 epsilon, delta, gamma, and zeta, but the contributions of different CD3 chains remain elusive. Using quantitative mass spectrometry, we simultaneously quantitated the phosphorylation of the immunoreceptor tyrosine-based activation motif (ITAM) of all CD3 chains upon TCR stimulation. A subpopulation of CD3 epsilon ITAMs was mono-phosphorylated, owing to Lck kinase selectivity, and specifically recruited the inhibitory Csk kinase to attenuate TCR signaling, suggesting that TCR is a self-restrained signaling machinery containing both activating and inhibitory motifs. Moreover, we found that incorporation of the CD3 epsilon cytoplasmic domain into a second-generation chimeric antigen receptor (CAR) improved antitumor activity of CAR-T cells. Mechanistically, the Csk-recruiting ITAM of CD3 epsilon reduced CAR-T cytokine production whereas the basic residue rich sequence (BRS) of CD3 epsilon promoted CAR-T persistence via p85 recruitment, Collectively, CD3 epsilon is a built-in multifunctional signal tuner, and increasing CD3 diversity represents a strategy to design next-generation CAR.
引用
收藏
页码:855 / +
页数:40
相关论文
共 50 条
  • [1] Analysis of cell types in apheresis material for CAR-T therapy: focus on patients with low CD3 counts
    Beifuss, E. Moutzouri
    Chanias, I.
    Luscher, B.
    Pabst, T.
    Bacher, U.
    Mansouri, B.
    Daskalakis, M.
    Jalowiec, K.
    SWISS MEDICAL WEEKLY, 2022, 152 : 26S - 26S
  • [2] Evaluation of Miltenyi ExpAct and TransAct CD3/28 Beads for CAR-T Cell Manufacturing
    Wang, Xiuyan
    Qu, Jinrong
    Stefanski, Jolanta
    Borquez-Ojeda, Oriana
    Hack, Anniesha
    He, Qing
    Wasielewska, Teresa
    Du, Fang
    Sadelain, Michel
    Riviere, Isabelle
    MOLECULAR THERAPY, 2016, 24 : S182 - S182
  • [3] A new CAR-T cell therapy for multiple myeloma
    Hosen, Naoki
    CANCER SCIENCE, 2022, 113 : 644 - 644
  • [4] CAR-T Cell Therapy
    Ahmad, Aamir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12)
  • [5] CAR-T cell therapy
    San Segundo, Lucrecia Yanez
    MEDICINA CLINICA, 2021, 156 (03): : 123 - 125
  • [6] Current Status of CAR-T Cell Therapy in Multiple Myeloma
    Reguera-Ortega, Juan Luis
    Garcia-Guerrero, Estefania
    Perez-Simon, Jose Antonio
    HEMATO, 2021, 2 (04): : 660 - 671
  • [7] CD3ε tunes CAR T cell anticancer activity
    Alexandra Flemming
    Nature Reviews Immunology, 2020, 20 : 520 - 521
  • [8] CD3ε tunes CAR T cell anticancer activity
    Flemming, Alexandra
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (09) : 520 - 521
  • [9] Total Car-T Cost of Care Beyond the Price of Car-T Cell Therapy in Patients with Multiple Myeloma
    Jagannath, Sundar
    Joseph, Nedra
    Crivera, Concetta
    Jackson, Carolyn C.
    Valluri, Satish
    Cost, Patricia
    Phelps, Hilary
    Slowik, Rafal
    Klein, Timothy
    Yu, Xueting
    Smolen, Lee
    Cohen, Adam D.
    BLOOD, 2021, 138
  • [10] The Application of Nanobody in CAR-T Therapy
    Bao, Chaolemeng
    Gao, Quanli
    Li, Lin-Lin
    Han, Lu
    Zhang, Bingxiang
    Ding, Yijin
    Song, Zongpei
    Zhang, Ruining
    Zhang, Jishuai
    Wu, Xian-Hui
    BIOMOLECULES, 2021, 11 (02) : 1 - 18